Salati M, et al. – This report aimed at offerring an overview of baseline and surgical characteristics and outcomes of patients submitted to lung resections for malignant lung disease as derived from the European Society of Thoracic Surgeons (ESTS) registry. Among the patients with primary lung cancer, 50.8% had Stage I disease and 23.2% Stage II disease; preoperative invasive mediastinal staging was performed in 70.3% of patients with computed tomography scan nodal enlargement and positron emission tomography scan nodal uptake. After anatomical lung resection, overall morbidity of 18.5% and mortality (30 days or in–hospital) of 2.6% were observed. Worse outcomes seemed associated with extent of resection, age ≥75 years, presence of cardiac comorbidity, predicted postoperative forced expiratory volume in 1 s <70% and open approach instead of video–assisted thoracic surgery.